---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-004651"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2025-04-10T23:59:59+00:00"
generated_at: "2026-05-23T17:17:41.875186+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# NextCure updates corporate presentation on LNCB74 trial; no specific data disclosed

## Summary
- Updated presentation for LNCB74, a clinical-stage candidate, furnished on April 10, 2025.
- Company engaging with investment community referencing updated materials.
- No new clinical data, enrollment figures, or milestones provided in the filing or exhibit.

## SEC filing metadata
- accession: 0001558370-25-004651
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2025-04-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837025004651/0001558370-25-004651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837025004651/nxtc-20250410x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-004651
- JSON: https://secwatch.observer/filing/0001558370-25-004651.json
- Plain text: https://secwatch.observer/filing/0001558370-25-004651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.